216 related articles for article (PubMed ID: 1360267)
1. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes.
Chaudhary PM; Mechetner EB; Roninson IB
Blood; 1992 Dec; 80(11):2735-9. PubMed ID: 1360267
[TBL] [Abstract][Full Text] [Related]
2. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype.
Drach D; Zhao S; Drach J; Mahadevia R; Gattringer C; Huber H; Andreeff M
Blood; 1992 Dec; 80(11):2729-34. PubMed ID: 1360266
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance activity in human lymphocytes.
Coon JS; Wang YZ; Bines SD; Markham PN; Chong AS; Gebel HM
Hum Immunol; 1991 Oct; 32(2):134-40. PubMed ID: 1720770
[TBL] [Abstract][Full Text] [Related]
4. P-glycoprotein expression and function in circulating blood cells from normal volunteers.
Klimecki WT; Futscher BW; Grogan TM; Dalton WS
Blood; 1994 May; 83(9):2451-8. PubMed ID: 7513198
[TBL] [Abstract][Full Text] [Related]
5. No evidence of significant activity of the multidrug resistance gene product in primary human breast cancer.
Hegewisch-Becker S; Staib F; Löning T; Pichlmeier U; Kröger N; Reymann A; Hossfeld DK
Ann Oncol; 1998 Jan; 9(1):85-93. PubMed ID: 9541688
[TBL] [Abstract][Full Text] [Related]
6. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells.
Chaudhary PM; Roninson IB
Cell; 1991 Jul; 66(1):85-94. PubMed ID: 1712673
[TBL] [Abstract][Full Text] [Related]
7. Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma.
Pilarski LM; Belch AR
Blood; 1994 Feb; 83(3):724-36. PubMed ID: 7507731
[TBL] [Abstract][Full Text] [Related]
8. Rhodamine 123-efflux from hematopoietic subpopulations and leukaemic blast populations marked by PerCP-conjugated monoclonal antibodies.
Beck J; Gekeler V; Ringger M; Handgretinger R; Niethammer D
Cancer Lett; 1996 Feb; 99(2):197-207. PubMed ID: 8616825
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection.
Choi K; Frommel TO; Stern RK; Perez CF; Kriegler M; Tsuruo T; Roninson IB
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7386-90. PubMed ID: 1678523
[TBL] [Abstract][Full Text] [Related]
10. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein activity in human Caucasian male lymphocytes does not follow its increased expression during aging.
Vilas-Boas V; Silva R; Gaio AR; Martins AM; Lima SC; Cordeiro-da-Silva A; de Lourdes Bastos M; Remião F
Cytometry A; 2011 Nov; 79(11):912-9. PubMed ID: 21905209
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833.
Egashira M; Kawamata N; Sugimoto K; Kaneko T; Oshimi K
Blood; 1999 Jan; 93(2):599-606. PubMed ID: 9885221
[TBL] [Abstract][Full Text] [Related]
13. A simplified approach to determining P-glycoprotein expression in peripheral blood mononuclear cell subsets.
Ford J; Hoggard PG; Owen A; Khoo SH; Back DJ
J Immunol Methods; 2003 Mar; 274(1-2):129-37. PubMed ID: 12609539
[TBL] [Abstract][Full Text] [Related]
14. A new procedure for the quantitative assessment of p-glycoprotein efflux pump associated with human T lymphocytes.
Vélez R; Sánchez Mdel C; Lopez P; Yamamura Y
Ethn Dis; 2008; 18(2 Suppl 2):S2-75-80. PubMed ID: 18646325
[TBL] [Abstract][Full Text] [Related]
15. Multidrug transporter P-glycoprotein 170 as a differentiation antigen on normal human lymphocytes and thymocytes: modulation with differentiation stage and during aging.
Pilarski LM; Paine D; McElhaney JE; Cass CE; Belch AR
Am J Hematol; 1995 Aug; 49(4):323-35. PubMed ID: 7639278
[TBL] [Abstract][Full Text] [Related]
16. The extracellular loop between TM5 and TM6 of P-glycoprotein is required for reactivity with monoclonal antibody UIC2.
Zhou Y; Gottesman MM; Pastan I
Arch Biochem Biophys; 1999 Jul; 367(1):74-80. PubMed ID: 10375401
[TBL] [Abstract][Full Text] [Related]
17. HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART.
Lucia MB; Rutella S; Leone G; Vella S; Cauda R
J Acquir Immune Defic Syndr; 2001 Aug; 27(4):321-30. PubMed ID: 11468419
[TBL] [Abstract][Full Text] [Related]
18. Drug-transporter proteins in clinical multidrug resistance.
Scheper RJ; Broxterman HJ; Scheffer GL; Meijer CJ; Pinedo HM
Clin Chim Acta; 1992 Mar; 206(1-2):25-32. PubMed ID: 1349270
[TBL] [Abstract][Full Text] [Related]
19. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.
Yamaguchi M; Kita K; Miwa H; Nishii K; Oka K; Ohno T; Shirakawa S; Fukumoto M
Cancer; 1995 Dec; 76(11):2351-6. PubMed ID: 8635042
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes.
Raghu G; Park SW; Roninson IB; Mechetner EB
Exp Hematol; 1996 Aug; 24(10):1258-64. PubMed ID: 8765502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]